Get started
Author

Mulu Z. Tesfay

Eastern and Venezuelan Equine Encephalitis Viruses Differ in Their Ability To Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis
2008 · Christina L. Gardner, Crystal W. Burke, et al. · Journal of Virology · 145
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
2024 · Conner Hartupee, Bolni Marius Nagalo, et al. · Frontiers in Immunology · 108
PDF
PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
2013 · Mulu Z. Tesfay, Amber C. Kirk, et al. · Journal of Virology · 78
Vesiculovirus Neutralization by Natural IgM and Complement
2014 · Mulu Z. Tesfay, Arun Ammayappan, et al. · Journal of Virology · 39
PDF
Alpha/Beta Interferon Inhibits Cap-Dependent Translation of Viral but Not Cellular mRNA by a PKR-Independent Mechanism
2007 · Mulu Z. Tesfay, Jun Yin, et al. · Journal of Virology · 37
Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer’s defenses
2025 · Tolulope O. Omolekan, Joy T. Folahan, et al. · Frontiers in Immunology · 20
PDF
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
2022 · Kah-Whye Peng, Timothy Carey, et al. · Vaccine · 14
PDF
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
2020 · Rianna Vandergaast, Timothy Carey, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 14
PDF
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers
2018 · Lukkana Suksanpaisan, Rong Xu, et al. · Molecular Therapy — Oncolytics · 12
PDF
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
2022 · Yuguo Zhang, Musa Gabere, et al. · Frontiers in Oncology · 7
PDF
Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
2024 · Khandoker Usran Ferdous, Mulu Z. Tesfay, et al. · Biomedicines · 6
PDF
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade
2024 · Mulu Z. Tesfay, Yuguo Zhang, et al. · Molecular Therapy Oncology · 5
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
2025 · Chelsae R. Watters, Oumar Barro, et al. · Molecular Therapy Oncology · 4
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response
2026 · Mulu Z. Tesfay, Aleksandra Cios, et al. · Journal for ImmunoTherapy of Cancer · 1
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models
2025 · Mulu Z. Tesfay, Aleksandra Cios, et al. · Frontiers in Immunology · 1
In vivo Safety and Immunoactivity of Oncolytic Jurona Virus in Hepatocellular Carcinoma: A Comprehensive Proteogenomic Analysis
2022 · Yuguo Zhang, Mulu Tesfay, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 4378: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
2026 · Mulu Z. Tesfay, Aleksandra Cios, et al. · Cancer Research
CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function
2026 · CY Chabu, R Kazmierczak, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract B022: Reprogramming Apoptotic Resistance in PDAC Through Synthetic Oncolytic Immunotherapy
2025 · Aleksandra Cios, Khandoker Usran. Ferdous, et al. · Cancer Research
Abstract 947: Engineering a synthetic oncolytic virus to overcome apoptotic resistance and induce immunogenic cell death in pancreatic ductal adenocarcinoma
2025 · Aleksandra Cios, Khandoker Usran Ferdous, et al. · Cancer Research
Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
2025 · Mulu Z. Tesfay, Aleksandra Cios, et al. · Cancer Research
Abstract 2155: Phage display discovery of Trop-2 peptide for targeted liposomal chemo-immunotherapy in lung cancer
2025 · Bahaa S. Mustafa, Bolni M Nagalo, et al. · Cancer Research
Abstract 950: Engineered oncolytic vesiculovirus downsizes pancreatic tumor and boosts immune response
2025 · Khandoker Usran Ferdous, Mulu Z. Tesfay, et al. · Cancer Research
Abstract B049: Oncolytic virotherapy as an effective tool to synergistically enhance therapeutic efficacy of standard systemic treatments for pancreatic cancer
2024 · Conner Hartupee, Amirsalar Mansouri, et al. · Cancer Research
Abstract 5004: Oncolytic Jurona-driven systemic and intratumoral immunotherapy combined with immune checkpoint blockade boost immune response and survival in hepatocellular carcinoma models
2024 · Mulu Z. Tesfay, Khandoker U. Ferdous, et al. · Cancer Research
Works count: 29
Citation count: 492
H-index: 9
I10-index: 9
Year
Topic
Type